Form 8-K - Current report:
SEC Accession No. 0001641172-25-009941
Filing Date
2025-05-13
Accepted
2025-05-13 16:05:10
Documents
13
Period of Report
2025-05-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 33861
  Complete submission text file 0001641172-25-009941.txt   207621

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gtbp-20250507.xsd EX-101.SCH 3024
3 XBRL LABEL FILE gtbp-20250507_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE gtbp-20250507_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3682
Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40023 | Film No.: 25939930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)